We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Highly Sensitive ELISA Technique for Bevacizumab Bioanalysis

News   Feb 01, 2018 | Original story from Bentham Science Publishers

 
Highly Sensitive ELISA Technique for Bevacizumab Bioanalysis

This is a schematic diagram of the ELISA for Bevacizumab. Credit: Bentham Science Publishers and Dr. Manal A. El-Gendy et al.

 
 
 

RELATED ARTICLES

Dual Anthrax-Plague Vaccine Effective in Multiple Animal Models

News

A dual vaccine against the causative agents of anthrax and the plague is effective in three animal models.

READ MORE

Treatment Eliminates Nicotine Addiction in Preclinical Tests

News

Scientists at Scripps Research have successfully tested a potential new smoking-cessation treatment in rodents.

READ MORE

150-year-old Drug Could Improve Cancer Radiation Therapy

News

A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE